Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
42.74
-1.47 (-3.33%)
Oct 22, 2024, 4:00 PM EDT - Market closed
Xenon Pharmaceuticals Market Cap
Xenon Pharmaceuticals has a market cap or net worth of $3.24 billion as of October 23, 2024. Its market cap has increased by 42.24% in one year.
Market Cap
3.24B
Enterprise Value
2.40B
1-Year Change
42.24%
Ranking
Category
Stock Price
$42.74
Market Cap Chart
Since November 5, 2014, Xenon Pharmaceuticals's market cap has increased from $142.20M to $3.24B, an increase of 2,177.20%. That is a compound annual growth rate of 36.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2024 | 3.24B | 7.45% |
| Dec 29, 2023 | 3.01B | 22.21% |
| Dec 30, 2022 | 2.47B | 53.02% |
| Dec 31, 2021 | 1.61B | 199.33% |
| Dec 31, 2020 | 538.40M | 58.77% |
| Dec 31, 2019 | 339.10M | 112.87% |
| Dec 31, 2018 | 159.30M | 213.58% |
| Dec 29, 2017 | 50.80M | -63.13% |
| Dec 30, 2016 | 137.80M | 19.20% |
| Dec 31, 2015 | 115.60M | -58.73% |
| Dec 31, 2014 | 280.10M | 96.98% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Perrigo Company | 3.52B |
| Amicus Therapeutics | 3.52B |
| TG Therapeutics | 3.48B |
| Apellis Pharmaceuticals | 3.36B |
| Dyne Therapeutics | 3.35B |
| Edgewise Therapeutics | 3.23B |
| Envista Holdings | 3.21B |
| Amedisys | 3.18B |